✦ LIBER ✦
WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection
✍ Scribed by M. Goldman; A. Schuster; C. Halliburn; G. Döring
- Book ID
- 117799380
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 61 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1569-1993
No coin nor oath required. For personal study only.